FDA approves Vraylar for treatment of bipolar I disorder and schizophrenia
Allergan plc and Gedeon Richter Plc. have announced that the U.S. Food and Drug Administration (FDA) has approved Vraylartm (cariprazine) capsules,…
Pharmaceuticals, Biotechnology and Life Sciences
Allergan plc and Gedeon Richter Plc. have announced that the U.S. Food and Drug Administration (FDA) has approved Vraylartm (cariprazine) capsules,…
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly reported that the Company’s Jardiance (empagliflozin) had reduced the risk of the…
Allergan and U.S. Women’s Health Alliance (USWHA), an organization focused on promoting high-quality, affordable healthcare for women, have announced an…
Horizon Discovery Group plc Enters Bioproduction Cell Line Licensing Agreement with LakePharma, Inc. Horizon Discovery Group plc, the international life…
Hikma Pharmaceuticals PLC, a multinational pharmaceutical group, has agreed to acquire 98.09% of the share capital of EIMC United Pharmaceuticals (EUP)…
Takeda Pharmaceutical Company Limited will participate in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs, vaccines,…
Alexion Pharmaceuticals, Inc. announced on September 1, 2015, that the European Commission has approved Strensiq (asfotase alfa) for long-term enzyme replacement…
The National Institute on Drug Abuse (NIDA) has announced that Adapt Pharma Limited, a partner of Lightlake Therapeutics Inc., has started a rolling…